Lista de obras - Per thor Straten - Dominio Público Uruguay

(GT)n Repeat Polymorphism in Heme Oxygenase-1 (HO-1) Correlates with Clinical Outcome after Myeloablative or Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation

artículo científico publicado en 2016

A Potential Role of Indoleamine 2,3-Dioxygenase-Specific T cells in Leishmania Vaccination ⬇️

artículo científico publicado el 8 de julio de 2011

A survivin specific T-cell clone from a breast cancer patient display universal tumor cell lysis

artículo científico publicado en 2008

Aberrant Expression of MHC Class II in Melanoma Attracts Inflammatory Tumor-Specific CD4 + T- Cells, Which Dampen CD8 + T-cell Antitumor Reactivity

artículo científico publicado en 2015

Acquired Immune Resistance Follows Complete Tumor Regression without Loss of Target Antigens or IFNγ Signaling.

artículo científico publicado en 2017

Actively personalized vaccination trial for newly diagnosed glioblastoma

scientific article published on 19 December 2018

Adoptive cell therapy with autologous tumor infiltrating lymphocytes and low-dose Interleukin-2 in metastatic melanoma patients

artículo científico publicado en 2012

Adoptive cell therapy with tumor infiltrating lymphocytes and intermediate dose IL-2 for metastatic melanoma

Analysis of Vδ1 T cells in clinical grade melanoma-infiltrating lymphocytes

artículo científico publicado en 2012

Antibody stabilization of peptide-MHC multimers reveals functional T cells bearing extremely low-affinity TCRs

artículo científico publicado en 2014

Association of a functional Indoleamine 2,3-dioxygenase 2 genotype with specific immune responses

artículo científico publicado en 2012

BRAF inhibition improves tumor recognition by the immune system: Potential implications for combinatorial therapies against melanoma involving adoptive T-cell transfer

artículo científico publicado en 2012

Bimodal ex vivo expansion of T cells from patients with head and neck squamous cell carcinoma: a prerequisite for adoptive cell transfer

artículo científico publicado en 2011

Broadening the repertoire of melanoma-associated T-cell epitopes.

artículo científico publicado en 2015

CD8 T-cell responses against cyclin B1 in breast cancer patients with tumors overexpressing p53.

artículo científico publicado en 2009

Cancer immunotherapy: from the lab to clinical applications-Potential impact on cancer centres' organisation

artículo científico publicado en 2016

Cancer treatment: the combination of vaccination with other therapies

artículo científico publicado en 2008

Changes in Peripheral Blood Level of Regulatory T cells in Patients with Malignant Melanoma During Treatment with Dendritic Cell Vaccination and Low-dose IL-2

artículo científico publicado en 2011

Characterization of Spontaneous Immune Responses against Long Peptides Derived from Bcl-X(L) in Cancer Patients Using Elispot

artículo científico publicado en 2012

Characterization of ex vivo expanded tumor infiltrating lymphocytes from patients with malignant melanoma for clinical application

artículo científico publicado en 2011

Characterization of mouse MAGE-derived H-2Kb-restricted CTL epitopes

artículo científico publicado en 2004

Chemokine Receptors and Exercise to Tackle the Inadequacy of T Cell Homing to the Tumor Site

Chemokine receptor engineering of T cells with CXCR2 improves homing towards subcutaneous human melanomas in xenograft mouse model

artículo científico publicado en 2018

Clonal expansion of renal cell carcinoma-infiltrating T lymphocytes

artículo científico publicado en 2013

Combined killing of cancer cells and cross presentation of tumor antigen by Vγ9Vδ2 T cells.

artículo científico publicado en 2015

Comment on "Reduced cytotoxic function of effector CD8+ T cells is responsible for indoleamine 2,3-dioxygenase-dependent immune suppression".

artículo científico publicado en 2009

Comparison of clinical grade type 1 polarized and standard matured dendritic cells for cancer immunotherapy

artículo científico publicado en 2012

Correlation between frequencies of blood monocytic myeloid-derived suppressor cells, regulatory T cells and negative prognostic markers in patients with castration-resistant metastatic prostate cancer.

artículo científico publicado en 2014

Cytotoxic T cells

artículo científico publicado en 2006

Data analysis as a source of variability of the HLA-peptide multimer assay: from manual gating to automated recognition of cell clusters

artículo científico publicado en 2015

Defining the critical hurdles in cancer immunotherapy

artículo científico publicado en 2011

Design and validation of conditional ligands for HLA-B08:01, HLA-B15:01, HLA-B35:01, and HLA-B44:05

artículo científico publicado en 2015

Differential expression of inhibitory or activating CD94/NKG2 subtypes on MART-1-reactive T cells in vitiligo versus melanoma: a case report

artículo científico publicado en 2002

Discovery of CD8 T cell epitopes in Merkel cell polyomavirus through combinatorial encoding with MHC multimers.

artículo científico publicado en 2013

Dissection of T-cell Antigen Specificity in Human Melanoma

artículo científico publicado en 2012

Dynamic changes of specific T cell responses to melanoma correlate with IL-2 administration

artículo científico publicado en 2003

Effector CD4 and CD8 T cells and their role in the tumor microenvironment

artículo científico publicado en 2012

Efficient tumor cell lysis mediated by a Bcl-X(L) specific T cell clone isolated from a breast cancer patient

artículo científico publicado en 2006

Eleventh international conference on progress in vaccination against cancer (PIVAC-11), 10-13 October 2011, Copenhagen, Denmark

artículo científico publicado en 2012

Exercise and cancer: from "healthy" to "therapeutic"?

artículo científico publicado en 2017

Exercise suppresses tumor growth through epinephrine- and IL-6-dependent mobilization and redistribution of NK cells.

artículo científico publicado en 2015

Exercise: A new role for an old tool.

artículo científico publicado en 2016

Expansion With IL-15 Increases Cytotoxicity of Vγ9Vδ2 T Cells and Is Associated With Higher Levels of Cytotoxic Molecules and T-bet

artículo científico publicado en 2020

Expansion of circulating CD56bright natural killer cells in patients with JAK2-positive chronic myeloproliferative neoplasms during treatment with interferon-α.

artículo científico publicado en 2014

Exploitation of gamma delta T cells in cancer immunotherapy as combined antigen-presenters and cancer cell killers

Expression and function of Kv1.3 channel in malignant T cells in Sézary syndrome

artículo científico publicado en 2019

Expression of stress-induced MHC class I related chain molecules on human melanoma

artículo científico publicado en 2002

Future perspectives in melanoma research "Melanoma Bridge", Napoli, November 30th-3rd December 2016. ⬇️

artículo científico publicado en 2017

Generation of autologous tumor-specific T cells for adoptive transfer based on vaccination, in vitro restimulation and CD3/CD28 dynabead-induced T cell expansion

artículo científico publicado en 2012

Genetic engineering of T cells for increased homing to the tumor site

artículo científico publicado en 2014

Genetically engineered cell factories produce glycoengineered vaccines that target antigen-presenting cells and reduce antigen-specific T-cell reactivity

scientific article published on 17 August 2018

Genome editing of tumor specific T cells for sustained functionality in a suppressive tumor microenvironment

artículo científico publicado en 2015

HAGE, a cancer/testis antigen with potential for melanoma immunotherapy: identification of several MHC class I/II HAGE-derived immunogenic peptides

artículo científico publicado en 2007

HLA-A24 and survivin: possibilities in therapeutic vaccination against cancer

artículo científico publicado en 2006

High frequency of T cells specific for cryptic epitopes in melanoma patients

artículo científico publicado en 2013

Identical T-cell receptor transcripts in multiple melanoma metastases

artículo científico publicado en 2002

Identification and characterization of survivin-derived H-2Kb-restricted CTL epitopes

artículo científico publicado en 2009

Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and Plasma

artículo científico publicado en 2019

Identification of a cyclin B1-derived CTL epitope eliciting spontaneous responses in both cancer patients and healthy donors

artículo científico publicado en 2010

Identification of an HLA-A3-restricted cytotoxic T lymphocyte (CTL) epitope from ML-IAP.

artículo científico publicado en 2004

Identification of heme oxygenase-1-specific regulatory CD8+ T cells in cancer patients

artículo científico publicado en 2009

Identification of identical TCRs in primary melanoma lesions and tumor free corresponding sentinel lymph nodes

artículo científico publicado en 2005

Identification of novel survivin-derived CTL epitopes

artículo científico publicado en 2004

Immune-suppressive properties of the tumor microenvironment

artículo científico

Immunogenicity of Bcl-2 in patients with cancer

artículo científico publicado en 2004

Immunogenicity of HLA-A1-restricted peptides derived from S100A4 (metastasin 1) in melanoma patients

artículo científico publicado en 2009

Immunogenicity of constitutively active V599EBRaf

artículo científico publicado en 2004

Immunological consequences of the sentinel lymph-node biopsy--lessons from a melanoma patient

artículo científico publicado en 2003

Immunological tumor destruction in a murine melanoma model by targeted LTalpha independent of secondary lymphoid tissue

artículo científico publicado en 2007

Immunotherapy for metastatic colorectal cancer: present status and new options

artículo científico publicado en 2012

Improved migration of tumor ascites lymphocytes to ovarian cancer microenvironment by CXCR2 transduction.

artículo científico publicado en 2017

In situ cytokine therapy: redistribution of clonally expanded T cells

artículo científico publicado en 2001

Increase of circulating CD4+CD25highFoxp3+ regulatory T cells in patients with metastatic renal cell carcinoma during treatment with dendritic cell vaccination and low-dose interleukin-2.

artículo científico publicado en 2010

Indoleamine 2,3-dioxygenase specific, cytotoxic T cells as immune regulators

artículo científico publicado en 2010

Integrating proteomic and functional genomic technologies in discovery-driven translational breast cancer research

artículo científico publicado en 2003

Interferon-α induces marked alterations in circulating regulatory T cells, NK cell subsets, and dendritic cells in patients with JAK2V617F-positive essential thrombocythemia and polycythemia vera

artículo científico publicado en 2015

Intratumoral interleukin-21 increases antitumor immunity, tumor-infiltrating CD8+ T-cell density and activity, and enlarges draining lymph nodes

artículo científico publicado en 2010

Long-Lasting Complete Responses in Patients with Metastatic Melanoma after Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes and an Attenuated IL2 Regimen.

artículo científico

Long-lasting disease stabilization in the absence of toxicity in metastatic lung cancer patients vaccinated with an HLA-A2-restricted epitope derived from indoleamine 2,3 dioxygenase

artículo científico publicado en 2013

Long-lasting disease stabilization in the absence of toxicity in metastatic lung cancer patients vaccinated with an epitope derived from indoleamine 2,3 dioxygenase

artículo científico publicado en 2013

Longitudinal immune monitoring of patients receiving intratumoral injection of a MART-1 T-cell receptor-transduced cell line (C-Cure 709).

artículo científico publicado en 2009

Longitudinal studies of clonally expanded CD8 T cells reveal a repertoire shrinkage predicting mortality and an increased number of dysfunctional cytomegalovirus-specific T cells in the very elderly

artículo científico publicado en 2006

MERTK Acts as a Costimulatory Receptor on Human CD8+ T Cells

scientific article published on 02 July 2019

Melanoma inhibitor of apoptosis protein (ML-IAP) specific cytotoxic T lymphocytes cross-react with an epitope from the auto-antigen SS56.

artículo científico publicado en 2009

Methods to improve adoptive T-cell therapy for melanoma: IFN-γ enhances anticancer responses of cell products for infusion

artículo científico publicado en 2012

Mutational analysis of oncogenes and tumor suppressor genes in human cancer using denaturing gradient gel electrophoresis

artículo científico publicado en 2002

Natural CD4+ T-cell responses against indoleamine 2,3-dioxygenase

artículo científico publicado en 2012

Parallel detection of antigen-specific T-cell responses by multidimensional encoding of MHC multimers.

artículo científico publicado en 2009

Peptide vaccination against multiple myeloma using peptides derived from anti-apoptotic proteins: a phase I trial

artículo científico publicado en 2016

Peptide-MHC Class I Tetramers Can Fail To Detect Relevant Functional T Cell Clonotypes and Underestimate Antigen-Reactive T Cell Populations.

artículo científico publicado en 2018

Pre-Vaccination Frequencies of Th17 Cells Correlate with Vaccine-Induced T-Cell Responses to Survivin-Derived Peptide Epitopes

artículo científico publicado en 2015

Regulators of apoptosis: suitable targets for immune therapy of cancer

artículo científico publicado en 2005

Review of clinical studies on dendritic cell-based vaccination of patients with malignant melanoma: assessment of correlation between clinical response and vaccine parameters

artículo científico publicado en 2008

RhoC a new target for therapeutic vaccination against metastatic cancer

artículo científico publicado en 2008

RhoH is important for positive thymocyte selection and T-cell receptor signaling

scientific journal article

Self-reactive T cells: suppressing the suppressors

artículo científico publicado en 2013

Spontaneous T-cell responses against peptides derived from the Taxol resistance-associated gene-3 (TRAG-3) protein in cancer patients.

artículo científico publicado en 2004

Spontaneous cytotoxic T-Cell reactivity against indoleamine 2,3-dioxygenase-2.

artículo científico publicado en 2011

Spontaneous immunity against Bcl-xL in cancer patients

artículo científico publicado en 2005

Successful treatment with Ipilimumab and Interleukin-2 in two patients with metastatic melanoma and systemic autoimmune disease

artículo científico publicado en 2014

Survivin-specific T-cell reactivity correlates with tumor response and patient survival: a phase-II peptide vaccination trial in metastatic melanoma

artículo científico publicado en 2012

T cell recognition of novel shared breast cancer antigens is frequently observed in peripheral blood of breast cancer patients

artículo científico publicado en 2019

T cell responses in melanoma patients after vaccination with tumor-mRNA transfected dendritic cells

article

T cell therapy in combination with Vemurafenib in BRAF mutated metastatic melanoma patients

artículo científico publicado en 2014

T-cell clonotypes in cancer

artículo científico publicado en 2004

T-cell responses to oncogenic merkel cell polyomavirus proteins distinguish patients with merkel cell carcinoma from healthy donors

artículo científico publicado en 2014

TAM-ing T cells in the tumor microenvironment: implications for TAM receptor targeting

scientific article published on 29 October 2019

TIL therapy broadens the tumor-reactive CD8(+) T cell compartment in melanoma patients.

artículo científico publicado en 2012

Targetless T cells in cancer immunotherapy

artículo científico publicado en 2016

The 1170 A-P single-nucleotide polymorphism (SNP) in the Her-2/neu protein (HER2) as a minor histocompatibility antigen (mHag).

artículo científico publicado en 2009

The Expression of IL-21 Is Promoted by MEKK4 in Malignant T Cells and Associated with Increased Progression Risk in Cutaneous T-Cell Lymphoma

artículo científico publicado en 2016

The JAK2V617F mutation is a target for specific T cells in the JAK2V617F-positive myeloproliferative neoplasms.

artículo científico publicado en 2016

The anti-apoptotic members of the Bcl-2 family are attractive tumor-associated antigens ⬇️

artículo científico publicado el 1 de agosto de 2010

The calreticulin (CALR) exon 9 mutations are promising targets for cancer immune therapy.

artículo científico publicado en 2017

The immune system strikes back: cellular immune responses against indoleamine 2,3-dioxygenase

artículo científico publicado en 2009

The immunodominant HLA-A2-restricted MART-1 epitope is not presented on the surface of many melanoma cell lines

artículo científico publicado en 2008

The immunogenicity of the hTERT540-548 peptide in cancer

artículo científico publicado en 2008

The melanoma inhibitor of apoptosis protein: a target for spontaneous cytotoxic T cell responses

artículo científico publicado en 2004

The paradoxical association between Bcl-2 expression and prognosis: does the immune system make the difference?

artículo científico publicado en 2005

The universal character of the tumor-associated antigen survivin

artículo científico publicado en 2007

Therapeutic cancer vaccines in combination with conventional therapy

artículo científico publicado en 2010

Therapeutic dendritic cell vaccination of patients with metastatic renal cell carcinoma: a clinical phase 1/2 trial

artículo científico publicado en 2008

Transfection of Tumor-Infiltrating T Cells with mRNA Encoding CXCR2

artículo científico publicado en 2016

Tryptophan 2,3-dioxygenase (TDO)-reactive T cells differ in their functional characteristics in health and cancer

artículo científico publicado en 2015

Tumor associated antigen specific T-cell populations identified in ex vivo expanded TIL cultures

artículo científico publicado en 2011

Unconventional cytokine profiles and development of T cell memory in long-term survivors after cancer vaccination

artículo científico publicado en 2009

Vaccination with autologous dendritic cells pulsed with multiple tumor antigens for treatment of patients with malignant melanoma: results from a phase I/II trial

artículo científico publicado en 2010

Voluntary Running Suppresses Tumor Growth through Epinephrine- and IL-6-Dependent NK Cell Mobilization and Redistribution

artículo científico publicado en 2016

Vγ9Vδ2 T Cells Concurrently Kill Cancer Cells and Cross-Present Tumor Antigens

artículo científico publicado en 2021

mRNA-transfected dendritic cell vaccine in combination with metronomic cyclophosphamide as treatment for patients with advanced malignant melanoma.

artículo científico publicado en 2016

Lista de obras de Per thor Straten

(GT)n Repeat Polymorphism in Heme Oxygenase-1 (HO-1) Correlates with Clinical Outcome after Myeloablative or Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation

A Potential Role of Indoleamine 2,3-Dioxygenase-Specific T cells in Leishmania Vaccination ⬇️

A survivin specific T-cell clone from a breast cancer patient display universal tumor cell lysis

Aberrant Expression of MHC Class II in Melanoma Attracts Inflammatory Tumor-Specific CD4 + T- Cells, Which Dampen CD8 + T-cell Antitumor Reactivity

Acquired Immune Resistance Follows Complete Tumor Regression without Loss of Target Antigens or IFNγ Signaling.

Actively personalized vaccination trial for newly diagnosed glioblastoma

Adoptive cell therapy with autologous tumor infiltrating lymphocytes and low-dose Interleukin-2 in metastatic melanoma patients

Adoptive cell therapy with tumor infiltrating lymphocytes and intermediate dose IL-2 for metastatic melanoma

Analysis of Vδ1 T cells in clinical grade melanoma-infiltrating lymphocytes

Antibody stabilization of peptide-MHC multimers reveals functional T cells bearing extremely low-affinity TCRs

Association of a functional Indoleamine 2,3-dioxygenase 2 genotype with specific immune responses

BRAF inhibition improves tumor recognition by the immune system: Potential implications for combinatorial therapies against melanoma involving adoptive T-cell transfer

Bimodal ex vivo expansion of T cells from patients with head and neck squamous cell carcinoma: a prerequisite for adoptive cell transfer

Broadening the repertoire of melanoma-associated T-cell epitopes.

CD8 T-cell responses against cyclin B1 in breast cancer patients with tumors overexpressing p53.

Cancer immunotherapy: from the lab to clinical applications-Potential impact on cancer centres' organisation

Cancer treatment: the combination of vaccination with other therapies

Changes in Peripheral Blood Level of Regulatory T cells in Patients with Malignant Melanoma During Treatment with Dendritic Cell Vaccination and Low-dose IL-2

Characterization of Spontaneous Immune Responses against Long Peptides Derived from Bcl-X(L) in Cancer Patients Using Elispot

Characterization of ex vivo expanded tumor infiltrating lymphocytes from patients with malignant melanoma for clinical application

Characterization of mouse MAGE-derived H-2Kb-restricted CTL epitopes

Chemokine Receptors and Exercise to Tackle the Inadequacy of T Cell Homing to the Tumor Site

Chemokine receptor engineering of T cells with CXCR2 improves homing towards subcutaneous human melanomas in xenograft mouse model

Clonal expansion of renal cell carcinoma-infiltrating T lymphocytes

Combined killing of cancer cells and cross presentation of tumor antigen by Vγ9Vδ2 T cells.

Comment on "Reduced cytotoxic function of effector CD8+ T cells is responsible for indoleamine 2,3-dioxygenase-dependent immune suppression".

Comparison of clinical grade type 1 polarized and standard matured dendritic cells for cancer immunotherapy

Correlation between frequencies of blood monocytic myeloid-derived suppressor cells, regulatory T cells and negative prognostic markers in patients with castration-resistant metastatic prostate cancer.

Cytotoxic T cells

Data analysis as a source of variability of the HLA-peptide multimer assay: from manual gating to automated recognition of cell clusters

Defining the critical hurdles in cancer immunotherapy

Design and validation of conditional ligands for HLA-B*08:01, HLA-B*15:01, HLA-B*35:01, and HLA-B*44:05

Differential expression of inhibitory or activating CD94/NKG2 subtypes on MART-1-reactive T cells in vitiligo versus melanoma: a case report

Discovery of CD8 T cell epitopes in Merkel cell polyomavirus through combinatorial encoding with MHC multimers.

Dissection of T-cell Antigen Specificity in Human Melanoma

Dynamic changes of specific T cell responses to melanoma correlate with IL-2 administration

Effector CD4 and CD8 T cells and their role in the tumor microenvironment

Efficient tumor cell lysis mediated by a Bcl-X(L) specific T cell clone isolated from a breast cancer patient

Eleventh international conference on progress in vaccination against cancer (PIVAC-11), 10-13 October 2011, Copenhagen, Denmark

Exercise and cancer: from "healthy" to "therapeutic"?

Exercise suppresses tumor growth through epinephrine- and IL-6-dependent mobilization and redistribution of NK cells.

Exercise: A new role for an old tool.

Expansion With IL-15 Increases Cytotoxicity of Vγ9Vδ2 T Cells and Is Associated With Higher Levels of Cytotoxic Molecules and T-bet

Expansion of circulating CD56bright natural killer cells in patients with JAK2-positive chronic myeloproliferative neoplasms during treatment with interferon-α.

Exploitation of gamma delta T cells in cancer immunotherapy as combined antigen-presenters and cancer cell killers

Expression and function of Kv1.3 channel in malignant T cells in Sézary syndrome

Expression of stress-induced MHC class I related chain molecules on human melanoma

Future perspectives in melanoma research "Melanoma Bridge", Napoli, November 30th-3rd December 2016. ⬇️

Generation of autologous tumor-specific T cells for adoptive transfer based on vaccination, in vitro restimulation and CD3/CD28 dynabead-induced T cell expansion

Genetic engineering of T cells for increased homing to the tumor site

Genetically engineered cell factories produce glycoengineered vaccines that target antigen-presenting cells and reduce antigen-specific T-cell reactivity

Genome editing of tumor specific T cells for sustained functionality in a suppressive tumor microenvironment

HAGE, a cancer/testis antigen with potential for melanoma immunotherapy: identification of several MHC class I/II HAGE-derived immunogenic peptides

HLA-A24 and survivin: possibilities in therapeutic vaccination against cancer

High frequency of T cells specific for cryptic epitopes in melanoma patients

Identical T-cell receptor transcripts in multiple melanoma metastases

Identification and characterization of survivin-derived H-2Kb-restricted CTL epitopes

Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and Plasma

Identification of a cyclin B1-derived CTL epitope eliciting spontaneous responses in both cancer patients and healthy donors

Identification of an HLA-A3-restricted cytotoxic T lymphocyte (CTL) epitope from ML-IAP.

Identification of heme oxygenase-1-specific regulatory CD8+ T cells in cancer patients

Identification of identical TCRs in primary melanoma lesions and tumor free corresponding sentinel lymph nodes

Identification of novel survivin-derived CTL epitopes

Immune-suppressive properties of the tumor microenvironment

Immunogenicity of Bcl-2 in patients with cancer

Immunogenicity of HLA-A1-restricted peptides derived from S100A4 (metastasin 1) in melanoma patients

Immunogenicity of constitutively active V599EBRaf

Immunological consequences of the sentinel lymph-node biopsy--lessons from a melanoma patient

Immunological tumor destruction in a murine melanoma model by targeted LTalpha independent of secondary lymphoid tissue

Immunotherapy for metastatic colorectal cancer: present status and new options

Improved migration of tumor ascites lymphocytes to ovarian cancer microenvironment by CXCR2 transduction.

In situ cytokine therapy: redistribution of clonally expanded T cells

Increase of circulating CD4+CD25highFoxp3+ regulatory T cells in patients with metastatic renal cell carcinoma during treatment with dendritic cell vaccination and low-dose interleukin-2.

Indoleamine 2,3-dioxygenase specific, cytotoxic T cells as immune regulators

Integrating proteomic and functional genomic technologies in discovery-driven translational breast cancer research

Interferon-α induces marked alterations in circulating regulatory T cells, NK cell subsets, and dendritic cells in patients with JAK2V617F-positive essential thrombocythemia and polycythemia vera

Intratumoral interleukin-21 increases antitumor immunity, tumor-infiltrating CD8+ T-cell density and activity, and enlarges draining lymph nodes

Long-Lasting Complete Responses in Patients with Metastatic Melanoma after Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes and an Attenuated IL2 Regimen.

Long-lasting disease stabilization in the absence of toxicity in metastatic lung cancer patients vaccinated with an HLA-A2-restricted epitope derived from indoleamine 2,3 dioxygenase

Design and validation of conditional ligands for HLA-B08:01, HLA-B15:01, HLA-B35:01, and HLA-B44:05